Categories: Esports

Ryan Fox Delivers Playoff Heroics at RBC Canadian Open for Second PGA TOUR Title

HUNTINGTON BEACH, Calif., June 8, 2025 – Srixon’s Ryan Fox continued his hot run on the PGA TOUR, capturing the 2025 RBC Canadian Open in another thrilling playoff victory – marking his second win in just four weeks.

- Advertisement -

Fox delivered a textbook performance on Sunday, carding a bogey-free 66 highlighted by a clutch 16-foot birdie putt on the 72nd hole to force a playoff. Echoing his performance at the ONEflight Myrtle Beach Classic just weeks earlier, Fox once again rose to the moment. With his Srixon ZXi Fairway Wood in hand, he delivered a pinpoint approach shot on the par-5 18th, leaving himself inside 12 feet and setting up the decisive birdie putt to claim his second PGA TOUR title.

- Advertisement -

“That shot I hit on 18 with 3-wood is probably the best shot I’ve ever hit,” said Fox. “It would’ve been nice to make it, but hey I’ll take it.”

- Advertisement -
ZXi Fairway Wood

Relying on his trademark precision and complete confidence in his Srixon equipment, Fox delivered a dominant performance throughout the week. He finished tied for first in strokes gained total and ranked inside the top 10 in both strokes gained: approach and greens in regulation – underscoring the elite ball-striking he’s known for during his entire career.

- Advertisement -

Fox’s victory adds to Srixon’s impressive run in 2025, reinforcing the brand’s reputation as the trusted choice of some of the best players in the world.

- Advertisement -

Fox’s winning setup includes:

- Advertisement -
  • Srixon ZXi 10.5° Driver
  • Srixon ZXi Fairway Wood (3)
  • Srixon ZXiU Utility (2i)
  • Srixon ZXi5 Irons (4i, 5i)
  • Srixon ZXi7 Irons (6i-PW)
  • Srixon Z-STAR XV Golf Ball
  • Cleveland Golf RTZ Wedge (50° MID, 56° MID, 60° LOW)

For more information about Srixon and Cleveland Golf products, visit us.dunlopsports.com.

- Advertisement -
TheNews Market

Recent Posts

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…

6 hours ago

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…

6 hours ago

Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings

May 29, 2026 21:18 ET  | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…

14 hours ago

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…

14 hours ago